Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease
https://doi.org/10.20996/1819-6446-2015-11-5-464-469
Abstract
Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF) development after coronary artery bypass graft (CABG) surgery in patients with ischemic heart disease (IHD) with the assessment of inflammation, sheer stress and myocardial injury indicators.
Material and methods. The study included 105 patients with IHD who were divided into two groups: patients of group 1 were treated with atorvastatin (59 patients, 81% males, mean age 62.1±7.5 years); patients of group 2 received no HMG-CoA reductase inhibitors (46 patients, 89% males, and mean age 61.7±8.1 years).
Results. Postoperative AF occurred more often in patients of group 2 (41.3% vs 16.9%; р=0.047). Laboratory analysis revealed the following: the levels of total leukocytes, interleukin-8, interleukin-10, C-reactive protein, fibrinogen, superoxide dismutase and troponin did not different significantly among the patients of two groups. Interleukin-6 level in preand postoperative period was significantly higher in patients of group 2 (35.4±28.5 pg/ml vs 24.1±14.8 pg/ml, р=0.03; 63.7±54.8 pg/ml vs 50.7±40.8 pg/ml, р=0.04, respectively).
Conclusion. Our study has shown that atorvastatin therapy contributed to the reduction of number of new cases of AF after CABG in patients with IHD. At that, the efficacy of atorvastatin therapy correlated with the size of left atrium and the severity of inflammatory response. Patients with atorvastatin therapy had significantly lower interleukin-6 level, as a proinflammatory marker, in preand postoperational period as compared with the patients without such treatment.
About the Author
O. A. Rubanenko
Samara State Medical University. Chapaevskaya ul., 89, Samara, 443099 Russia
Samara Regional Clinical Cardiology Clinic. Aerodromnaya ul., 43, Samara,443070 Russia
Russian Federation
Russian Federation
References
1. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atri- al fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-61.
2. Sakamoto H, Watanabe Y, Satou M. Do preoperative statins reduce atrial fibrillation after coronary ar- tery bypass grafting? Ann Thorac Cardiovasc Surg 2011; 17: 376-82.
3. Shhukin Ju.V., Rubanenko A.O., Germanov A.V., Tereshina O.V. Risk factors for ischemic stroke in pa- tients with permanent atrial fibrillation. Vestnik Aritmologii 2012; 67: 20-5. In Russian (Щукин Ю.В., Рубаненко А.О., Германов А.В., Терешина О.В. Факторы риска развития ишемического инсуль- та у пациентов с постоянной формой фибрилляции предсердий. Вестник Аритмологии 2012; 67: 20-5).
4. Miceli A, Fino C, Fiorani B, et al. Effects of preoperative statin treatment on the incidence of postoper- ative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2009; 87: 1853-8.
5. Aydın U, Yılmaz M, Düzyol Ç et al. Efficiency of postoperative statin treatment for preventing new-on- set postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting: A prospective randomized study. Anatol J Cardiol 2015; 15(6):491-5.
6. Elgendy IY, Mahmoud A, Huo T, et al. Meta-analysis of 12 trials evaluating the effects of statins on de- creasing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2015; 115(11): 1523-8.
7. Men EE, Yıldırımtürk O, Tuğcu A, et al. The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery. Anatol J Cardiol 2008; 8: 206-12
8. Liakopoulos OJ, Dörge H, Schmitto JD, et al. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006; 54: 250-4.
9. Diez J. Profibrotic effects of angiotensin II in the heart a matter of mediators. Hypertension 2004; 43: 1164.
10. Mariscalco G., Engstrom K.G., Ferrarese S. et al. Relation-ship between atrial histopathology and atri- al fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg 2006; 131: 1364-72.
11. Engelmann M., Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26(20): 2083-92.
12. Dereli Y, Ege E, Kurban S, et al. Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting. J Int Med Res 2008; 36(6): 1248-54.
13. Martínez-Comendador JM, Alvarez JR, Mosquera I et al. Preoperative statin treatment reduces sys- temic inflammatory response and myocardial damage in cardiac surgery. Eur J Cardiothorac Surg 2009; 36(6): 998-1005.
14. Montaigne D, Marechal X, Lefebvre P et al. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops. J Am Coll Cardiol 2013; 62(16): 1466-73.
15. Parsaee M, Moradi B, Esmaeilzadeh M et al. New onset atrial fibrillation after coronary artery bypasses grafting; an evaluation of mechanical left atrial function. Arch Iran Med 2014; 17(7): 501-6.
16. Jakubova M, Mitro P, Stancak B et al. The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients. Interact Cardiovasc Thorac Surg 2012; 15: 1007-12.
Review
For citations:
Rubanenko O.A. Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease. Rational Pharmacotherapy in Cardiology. 2015;11(5):464-469. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-5-464-469
Views:
767
Email this article 